Growing community of inventors

Seoul, South Korea

Eun Joo Nam

Average Co-Inventor Count = 4.54

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Eun Joo NamHee Sun Kim (4 patents)Eun Joo NamDong Wook Kang (4 patents)Eun Joo NamYoung Ho Kim (4 patents)Eun Joo NamChan Mi Joung (4 patents)Eun Joo NamJee Woo Lee (4 patents)Eun Joo NamHee Jin Ha (4 patents)Eun Joo NamZungyoon Yang (1 patent)Eun Joo NamHye Seong Lim (1 patent)Eun Joo NamYou Suk Suh (1 patent)Eun Joo NamHyun-Tak Jin (1 patent)Eun Joo NamEun Joo Nam (6 patents)Hee Sun KimHee Sun Kim (22 patents)Dong Wook KangDong Wook Kang (21 patents)Young Ho KimYoung Ho Kim (20 patents)Chan Mi JoungChan Mi Joung (15 patents)Jee Woo LeeJee Woo Lee (9 patents)Hee Jin HaHee Jin Ha (4 patents)Zungyoon YangZungyoon Yang (4 patents)Hye Seong LimHye Seong Lim (4 patents)You Suk SuhYou Suk Suh (4 patents)Hyun-Tak JinHyun-Tak Jin (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Medifron Dbt Co., Ltd. (4 from 4 patents)

2. Daewoong Pharmaceutical Co., Ltd. (3 from 77 patents)

3. Genexine, Inc. (1 from 24 patents)

4. Progen Co., Ltd. (1 from 2 patents)


6 patents:

1. 11339197 - Modified EGF protein, production method therefor, and use thereof

2. 11135262 - Methods of treating cervical cancer

3. 8580848 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof

4. 8507553 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof

5. 8455542 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof

6. 8263649 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/23/2026
Loading…